EUVIMEDEUVIMED entdecken
Open Access

Dysregulated Proline Metabolism Exacerbates Hepatocellular Carcinoma Metastasis via EPRS1-Mediated mRNA Translation

Hui Zhang, Leirong Gu, Xiameng Su, Wanjin Chen, Ming Tan, Haibo Yu, Hongzhong Zhou, Tingting Gao, Zhiling Wang, Xinyan Chen, Weixian Chen, Juan Chen und 1 weitere

Cancer Communications · 2026

DOI: 10.34133/cancomm.0028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Communications, 2026. Verfasst von Hui Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), The Second Affiliated Hospital, Chongqi…. Hauptthemen laut MEDLINE: Liver Neoplasms, Proline, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Key Technologies R&D Program, National Natural Science Foundation of China, Chongqing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic reprogramming is a hallmark of hepatocellular carcinoma (HCC), and amino acid reprogramming plays an important role in its metastatic progression. However, the function of amino acid reprogramming in HCC metastatic progression remains unclear. This study aimed to elucidate the function and mechanism of amino acid reprogramming, particularly focusing on proline metabolism, in driving HCC metastasis.

Methods

HCC cohort and multiple HCC models were enrolled to investigate the role of amino acid reprogramming in HCC metastatic progression. The pro-metastatic effect of l -proline in HCC was consistently validated across in vitro and in vivo studies. Ribosome profiling (Ribo-seq) and l -proline pull-down were used to investigate the mechanism of proline-mediated HCC metastasis.

Results

Based on metabolomics and proteomics, we found that proline metabolism was enhanced during HCC metastasis, as evidenced by increased proline levels and proline metabolism-related enzymes in both HCC metastatic patients and mice. Moreover, high levels of proline were found to promote HCC metastasis. Mechanistically, l -proline directly interacted with glutamyl-prolyl-tRNA synthetase 1 (EPRS1) at its Glu 1123 residue, thereby selectively enhancing the translation of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α (PIK3CA), AKT serine/threonine kinase 3 (AKT3), and integrin subunit β1 (ITGB1). Importantly, the enhanced protein translation could be abolished by bersiporocin, an EPRS1 inhibitor that prevents l -proline binding to EPRS1. Finally, the inhibitory effect of bersiporocin on HCC metastasis was confirmed in patient-derived orthotopic xenograft models.

Conclusions

Our findings not only revealed the critical role of l -proline-bound EPRS1 in promoting HCC metastasis but also indicated that inhibiting this binding could be a promising strategy to prevent metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsProlineCarcinoma, HepatocellularHumansAnimalsMiceMetabolic ReprogrammingCell Line, TumorProtein BiosynthesisNeoplasm MetastasisMaleRNA, MessengerGene Expression Regulation, NeoplasticMice, Nude

Substanzen

ProlineRNA, Messenger

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), The Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.
  • Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongq…
  • Department of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, P. R. China.
  • Department of Laboratory Medicine, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Health Science Center, Shenzhen University, Shenz…

Förderung

  • Key Technologies R&D Program
  • National Natural Science Foundation of China
  • Chongqing Natural Science Foundation

Zitieren

APA

Zhang, H., Gu, L., Su, X., Chen, W., Tan, M., Yu, H., Zhou, H., Gao, T., Wang, Z., Chen, X., Chen, W., Chen, J., & Cheng, S. (2026). Dysregulated Proline Metabolism Exacerbates Hepatocellular Carcinoma Metastasis via EPRS1-Mediated mRNA Translation. Cancer Communications. https://doi.org/10.34133/cancomm.0028

Vancouver

Zhang H, Gu L, Su X, Chen W, Tan M, Yu H, et al. Dysregulated Proline Metabolism Exacerbates Hepatocellular Carcinoma Metastasis via EPRS1-Mediated mRNA Translation. Cancer Communications. 2026. doi:10.34133/cancomm.0028

BibTeX
@article{Zhang2026,
  author = {Zhang, Hui and Gu, Leirong and Su, Xiameng and Chen, Wanjin and Tan, Ming and Yu, Haibo and Zhou, Hongzhong and Gao, Tingting and Wang, Zhiling and Chen, Xinyan and Chen, Weixian and Chen, Juan and Cheng, Shengtao},
  title = {Dysregulated Proline Metabolism Exacerbates Hepatocellular Carcinoma Metastasis via EPRS1-Mediated mRNA Translation},
  journal = {Cancer Communications},
  year = {2026},
  doi = {10.34133/cancomm.0028}
}
Kostenlos starten →